Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Visit the company website

Stock Quote & Recent News Neovasc Inc. T.NVCN

Alternate Symbol(s):  NVCN

Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSX:NVCN)

Fundamentals Snapshot (TSX:NVCN)

Bullboard Posts (TSX:NVCN)

Bull Sh**** Neovasc regains compliance with Nasdaq

I called that bulls*****. They say Neovasc regains compliance with Nasdaq bid    This company has split so many times that...
licari - 13 days ago

RE:Class action

you may have likely seen this since... https://neovasc.com/newsreleases/neovasc-announces-complete-dismissal-of-securities-class-action...
Monty2469 - March 7, 2022

💥

Let's go
licari - February 11, 2022

Neovasc Reducer™ Demonstrates Cost Savings

VANCOUVER and MINNEAPOLIS, Feb. 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the...
Betteryear2 - February 4, 2022

Class action

Anyone know of any updates on the proposed class action against Neovasc for the shoddy FDA application?
ENEMENEMYNEMO - August 30, 2021

Submission of COSIRA-II Protocol Supplement to FDA

VANCOUVER and MINNEAPOLIS, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company...
Betteryear2 - August 17, 2021

follow t.nvcn on

Visit the company website


TWITTER


IR CONTACT

Phone: 604.270.4344
Fax: 604.270.4384

13562 Maycrest Way
Suite 5138 Richmond
British Columbia
Canada V6V 2J7